Long-term safety evaluation of Mentor breast implants in Chinese women
Official title: MNT202401: Post Market Clinical Follow up for Mentor Breast Implants
Run by Johnson & Johnson Medical (Shanghai) Ltd. · NCT06510205 · Data updated 2026-11-12
This study is trying to see how safe Mentor breast implants are for Chinese women by looking at their pain levels and satisfaction over five years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | Women only |
| Enrollment | 6111 (estimated) |
| Sponsor | Johnson & Johnson Medical (Shanghai) Ltd. Industry-sponsored |
| Locations | 4 sites (Chengdu and 3 other locations) |
| Status | Recruiting |
| Started | July 14, 2024 |
| Main results expected | June 30, 2034 |
| Study ends | December 31, 2034 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06510205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 22 and older who have received Mentor breast implants and can provide informed consent.
✕Probably not a fit
Patients who have not received Mentor breast implants or are under 22 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects safety data on Mentor breast implants over a 5-year follow-up period in the Chinese population. It aims to assess postoperative pain and participant satisfaction levels, gathering insights into clinical experiences to inform future product development. The study plans to enroll at least 300 subjects across multiple medical institutions in China, ensuring a diverse representation of experiences with the implants.
Why it matters
Potential benefit: If successful, this study could provide valuable safety data that enhances the understanding of Mentor breast implants' long-term effects, leading to improved patient outcomes.
How similar studies have gone: Other observational studies on breast implants have shown success in evaluating safety and satisfaction, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women who have received Mentor breast implants per product instructions; 2. Participants must possess the ability to comprehend the study procedures, give consent for the use of their preoperative and surgical data, and agree to take part in postoperative follow-up assessments. Additionally, they should possess the necessary civil capacity, be capable of reading and writing, and willingly provide informed consent by signing the consent form. 3. Aged not less than 18 years at the time of implantation surgery (for products with registration license Guoxie Zhujin 20223130323, the participant's age should be not less than 22 years). Exclusion Criteria: * Not applicable
Where it's running
-
Sichuan Huamei Zixin Medical Aesthetic Hospital
Chengdu, China Recruiting -
Yunnan Huamei Meilai Cosmetology Hospital
Kunming, China Recruiting -
Shenzhen Yixing Medical Cosmetology Hospital
Shenzhen, China Recruiting -
Shenzhen Junke Medical Cosmetology Clinic
Shenzhen, China Recruiting
Study contacts
- Study coordinator: Study Contact
- Email: ygu51@its.jnj.com
- Phone: +86 15692105615
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improved Breast Enlargement Using Your Own Fat Tissue
This study tests a temporary device to help your own fat grafting for breast enlargement stay in place and keep volume after surgery.
-
Breast implant study to see how Luna implants perform after surgery
This study tests whether Eurosilicone Luna breast implants stay intact and keep their shape over 10 years in women aged 18–65 undergoing cosmetic or reconstructive breast surgery.
-
Autologous Free Dermal Graft Support in Vertical Scar Breast Reduction
This study tests whether using a patient’s own skin graft to support the lower pole helps keep the breast shape after a vertical scar breast reduction.
-
SPSIP Block to Help Pain After Breast Reduction Surgery
A randomized trial tests whether adding an ultrasound-guided SPSIP block can lower opioid use in the first 24 hours after bilateral breast reduction surgery.
-
Bilateral rhomboid intercostal block to reduce pain after breast implant surgery
This trial will test whether adding an ultrasound-guided bilateral rhomboid intercostal block to general anesthesia reduces pain and tramadol use after elective bilateral breast implant surgery in adults aged 18–65.
-
Nipple reconstruction with cross-linked hyaluronic acid after mastectomy
This trial will test whether adding a cross-linked hyaluronic acid injection to areola micropigmentation helps women who had a mastectomy achieve better nipple projection, appearance, and satisfaction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.